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Abstract
Background: Although B cells are important as antigen presenting cells (APC) during the immune response, their
role in DNA vaccination models is unknown.
Methods: In this study in vitro and in vivo experiments were performed to evaluate the ability of B cells to protect
mice against Mycobacterium tuberculosis challenge.
Results: In vitro and in vivo studies showed that B cells efficiently present antigens after naked plasmid pcDNA3
encoding M. leprae 65-kDa heat shock protein (pcDNA3-Hsp65) internalization and protect B knock-out (BKO) mice
against Mycobacterium tuberculosis infection. pcDNA3-Hsp65-transfected B cells adoptively transferred into BKO
mice rescued the memory phenotypes and reduced the number of CFU compared to wild-type mice.
Conclusions: These data not only suggest that B cells play an important role in the induction of CD8 T cells but
also that they improve bacterial clearance in DNA vaccine model.
Background
DNA vaccines consist of the specific gene of interest
cloned into a bacterial plasmid that is engineered for
optimal expression in eukaryotic cells, thereby leading
to protective immune responses. In contrast with subu-
nit vaccines, in DNA vaccination the immunogen is
synthesized within the host by cells that have taken up
the antigen-encoding DNA. Consequently, DNA vac-
cines join the advantages of subunit vaccines with the
ability to generate antigens endogenously making them
accessible to presentation. Moreover, CpG motifs in
bacterial DNA can elicit innate immune response via
Toll-like receptor 9-dependent pathway interfering with
T cell activation [1,2]. One intriguing aspect of DNA
vaccination involves the mechanism by which the
encoded antigen is processed and presented to the
immune system. Studies with bone marrow-chimeric
mice have suggested that bone marrow-derived APCs
play a key role in the induction of the immune response
after DNA vaccination [1]. We previously demonstrated
that intramuscular (i.m.) delivery of pcDNA3 encoding
M. leprae 65-kDa heat shock protein (pcDNA3-Hsp65)
results in activation of immune response, as well as pro-
tection against virulent M. tuberculosis challenge [3,4].
Despite the efficacy of DNA vaccines delivered by i.m.
injection, little is known about the tissue distribution of
plasmid as well as the cells involved in the uptake of
pcDNA3-HSP65 in vivo. We have previously shown that
pcDNA3-HSP65 can be uptaken by B cells in vivo [5].
These findings greatly encouraged us to analyze the role
of B cell in DNA vaccines.
It was suggested that the uptake of plasmid DNA by
B cells after intrasplenic injection also contributes to
endogenous synthesis of antigen and presentation [6].
B cells may play a key role in T-cell-mediated immunity
either acting as antigen-presenting cells or as antigenic
reservoirs, which result in amplification of the immune
response. In protein-based vaccines, B cells showed
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extra and essential antigen presentation capacity over
and above that provided by dendritic cells. Furthermore,
BCR-mediated uptake may make them efficient APCs
even at low Ag doses [7,8]. It was shown that antigen-
specific B cells are the main APC responsible for the
clonal expansion of antigen specific CD4 T cells in
the lymph nodes after protein immunization [8]. On the
other hand, B cells can activate CD8 T cells specifically
but require CD4 T help. Interestingly, CD8 T cell acti-
vation can result either from the presentation of the
cytotoxic (CTL) and helper T lymphocytes epitopes by
the same antigen presenting B lymphocyte or from a
sequential presentation of the two epitopes by two dif-
ferent antigen-presenting B lymphocytes [9].
It has been shown that priming with a low dose of B
cells transgenic for the dominant epitope (NP366-374)
of the influenza virus nucleoprotein is highly efficient in
inducing protective memory CTL response and the pro-
tection from disease is mediated by central memory
CD8 T cells [10]. Despite the differences between these
approaches and DNA vaccination they demonstrated the
importance of B cells in inducing memory CD8 T cells.
In the present study the role of B lymphocytes as anti-
gen presenting cells and also in the generation of mem-
ory T cells was evaluated in vivo after plasmid DNA
internalization. The results obtained herein open per-
spectives to the development of DNA vaccine strategies
and highlight the importance of B cells in this model.
Methods
Mice and immunization protocol
In this study we used 6- to 8-week-old mice of the fol-
lowing strains: C57BL/6 wild-type (WT) and B cell defi-
cient (BKO; μ chain-/-) mice. The mice were bred and
maintained under specific pathogen-free conditions in
the animal house of the Medical School of Ribeirão
Preto, University of São Paulo, Ribeirão Preto, São
Paulo, Brazil. Gene-deficient mice were obtained from
the Jackson laboratories (Bar Harbor, ME). All experi-
ments were performed in accordance with the guidelines
of the Animal Care Committee (CETEA) of the Univer-
sity, protocol number 172/2005. pcDNA3-Hsp65 and
empty plasmid were purified on an endofree QIAGEN
plasmid column, as previously described [4]. Mice were
injected into quadriceps muscle with 100 μg/mouse of
naked plasmid DNA in 25% PBS-sucrose (100 μl total
volume; 50 μl each one). The mice were immunized
three times in fifteen days interval and euthanized on
days 15 and 30 after the last immunization.
T lymphocytes proliferation assays
The spleens of immunized mice were aseptically col-
lected and cultured in complete RPMI medium [RPMI
1640 (Invitrogen) containing 2 mM L-glutamine,
50 mM 2-mercaptoethanol, 100 units/mL penicillin,
100 mg/mL streptomycin (Sigma-Aldrich Co.), and
10% heat-inactivated fetal calf serum (FCS) (Invitro-
gen)], in the presence of peritoneal macrophages and
50 μg of recombinant Hsp65 for three days. The
T lymphocytes were sorted using anti-CD8 or anti-
CD4 antibodies linked to magnetic beads (MACS®
MicroBeads System - Miltenyi Biotec). The B lympho-
cytes were obtained by negative selection (> 90%
CD19+) using anti-CD43 antibody linked to magnetic
beads (MACS). They were electroporated 300 V, 150
μF and 100 Ω in the GenePulser Xcell™ (Bio-Rad). It
was used 10 μg of pcDNA3-Hsp65 or empty vector to
1 × 106 cells (5 × 106/mL) in Opti-MEM (Invitrogen).
The cells were cultured in 96 wells culture cluster,
round bottom, 1 × 105 per well, in complete RPMI
medium. After three days, 1 × 106 CFSE-stained T
CD4 or T CD8 lymphocytes were added and cultured
for more three days. T cells proliferation was mea-
sured by the dilution of intracellular CFSE staining
detected by flow cytometry (FACSort™ - BD
Bioscience). As positive control some T cells were
treated with concanavalin A (4 μg/mL).
Real-time PCR
After electroporation, the B cells were cultured in 24
wells culture cluster (2 × 105 per well) for three days.
The T lymphocytes (obtained as previously described)
were added for additional three days. Then, the cells
were collected in 1 mL of TriZol® reagent (Invitrogen)
and the RNA was extracted according to the manufac-
turer protocol. The total RNA was treated with DNAseI
amplification grade (Invitrogen) and cDNA synthesis
was made using SuperScriptII (Invitrogen) according to
manufacturer’s instructions. In each real-time reaction
was used 200 ng of cDNA (GeneQuant II- Amershan-
Pharmacia) and 0,1 μg/μL of each primer (sense and
anti-sense). It was used the Platinum® SYBR® Green
qPCR SuperMix-UDG (Invitrogen) and the reactions
were performed in Rotor-gene (Corbett Life Science,
Mortlake, NSW, Australia). The Rotor-gene 6000 soft-
ware was used to calculate the relative expression of
each gene in APCs samples trasnfected with pcDNA3-
HSP65 or empty vector compared with the mock
electroporated cells. The beta-actin gene was used as
integrity samples control and primers sequences were:
b-actina sense AGC TGC GTT TTA CAC CCT TT; b-
actina anti-sense AAG CCA TGC CAA TGT TGT CT;
GATA-3 sense AGG AGT CTC CAA GTG TGC GAA;
GATA-3 anti-sense TTG GAA TGC AGA CAC CAC
CT; T-bet sense CCC CTG TCC AGT CAG TAA CTT;
T-bet anti-sense CTT CTC TGT TTG GCT GGC T;
Foxp3 sense ACA ACC TGA GCC TGC ACA AGT;
Foxp3 anti-sense GCC CAC CTT TTC TTG GTT TTG.
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Adoptive transfer assays
B lymphocytes were electroporated, as described above
and 1 × 106 cells were injected into the retro-orbital
plexus of WT and BKO mice. After seven days, the
mice were euthanized for analysis of CD44 and CD62L
memory markers on spleen T cells, by flow cytometry in
FACSort™(BD Bioscience). The antibodies used were all
purchased from BDPharMingen and the analysis was
made using the CellQuest® software (BD Biosciences).
Another group of mice were challenged with 1 × 105
virulent M. tuberculosis strain H37Rv (ATCC 27294) by
intranasal route on day seven post-immunization. Thirty
days after the infection, the mice were euthanized, the
lungs were collected and the colony-forming units
(CFU) of M. tuberculosis were determined by serial
10-fold dilution of lung homogenate on Middlebrook
7H11 agar enriched with 10% of heat-inactivated FCS.
CFU Petri dishes were incubated at 37°C for 4 weeks and
the number of colonies was visually counted. Results are
expressed as mean log10 values per gram of tissue.
Statistical Analysis
Statistical determinations of the difference between
means of experimental groups were performed using
one-way analysis of variance (ANOVA) followed by
Tukey post test. Differences that provided P value less
than 0.05 were considered to be statistically significant.
Results and Discussion
Plasmid DNA has been delivered in vivo to express the
encoded gene for several years since 1990. Nevertheless,
the mechanisms of immune system activation by DNA
vaccines are not complete elucidated [11]. To evaluate
whether transfected B cells are able to induce both
T lymphocytes proliferation and cytokine production,
Hsp65-specific CD4 and CD8 T cells were induced
through i.m. immunization of C57BL/6 mice with three
doses of pcDNA3-Hsp65 at a 2-week interval. First, we
analyzed the proliferation of spleen-sorted CD4 and
CD8 T cells, which were obtained on day 15 after the
last immunization and stimulated with recombinant
Hsp65 for three days. Afterward, these T cells were co-
cultured with pcDNA3-Hsp65-electroporated B cells, for
three days. By this time point CD4 or CD8 T cells pro-
liferation was not observed (Figure 1A), possibly due to
low number of Hsp65-specific T cells. On the other
hand, when transfected B cells were co-cultured with
spleen-sorted CD4 and CD8 T cells obtained on day
30 after the last immunization, in the same conditions,
they were able to induce CD4 and CD8 T cells prolifera-
tion, which was significantly higher than that from mock
vector-electroporated cells (Figure 1B). This result sug-
gests that pcDNA3-Hsp65-electroporated B lymphocytes
can induce T cells activation in our vaccine model.
Since transfected B cells were effective in inducing
CD4 and CD8 T cells activation, we asked whether
they could modulate the expression of the following
T cell transcription factors: T-bet, GATA3 and Foxp3,
which are master regulators of Th1, Th2 and regula-
tory T cell development respectively. To this end,
T-bet, GATA3 and Foxp3 expression were examined
by real-time RT-PCR after in vitro stimulation. Analy-
sis of T cells obtained on day 15 after the last immuni-
zation and cultured with transfected APC showed that
B cells were able to induce GATA-3 and T-bet expres-
sion in CD8 T cells, while the three transcription fac-
tors were expressed in CD4 T cells (Figure 1C). On
the contrary, when T cells obtained on day 30 after
the last immunization were cultured with B cells,
T-bet expression occurred only in CD8 T populations
(Figure 1D). This remaining T-bet expression can drive
the interferon-g production. These findings indicate
that transfected B cells can modulate CD4 and CD8
T cells activation profile and additionally play an
important role in the development of CD8 T cells
immune response.
In order to evaluate the true value of B cells in anti-
gen presentation, this APC electroporated with both
pcDNA3-Hsp65 and empty vector was adoptively trans-
ferred to B cell-deficient mice (BKO) and on day 7 after
this procedure the phenotype of CD4 and CD8 T cell
populations from spleen were analyzed by flow cytome-
try. As shown in Figure 2A, pcDNA3-Hsp65-tranfected
B cells adoptively transferred into BKO mice were able
to induce a significant increase in the percentage of cen-
tral memory (CM) CD8+ CD44hi CD62Lhi T cell subsets
[12] when compared with WT mice that received the
same treatment. On the other hand, there was no signif-
icant difference in the percentage of CM CD4+ CD44hi
CD62Lhi T cell subsets (Figure 2B). These in vivo assays
not only show that B cells were able to act as APC but
also that they had capacity to activate CD8 T lympho-
cytes and promote the generation of memory CD8
T cells. These in vivo results are in agreement with the
above findings where B cells presented an important
role mainly in the development of CD8 T cells immune
response. Our results are consistent with data of Casti-
glioni et al. [10] where transgenic B cells were used as
APC vaccine and were highly efficient in inducing anti-
virus protective immunity mediated by central memory
CD8 T cells. On the basis of these results we next evalu-
ated the role of transfected B cells adoptively transferred
in experimental tuberculosis. The role of B cells in the
protection against experimental tuberculosis has been
reported as a controversial issue [13,14] which might be
due to the several animal models and the variety of both
routes and strains used. CFU recovery from the lungs,
an important parameter to evaluate the course of
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experimental tuberculosis showed that BKO mice that
were injected with pcDNA3-Hsp65-electroporated B
cells presented a significant reduction in the number of
CFU when compared with WT mice. Curiously, there
was no difference in the number of CFU recovered from
the lungs of BKO mice immunized with both the
vector-transfected cells and pcDNA3-Hsp65 B cells
(Figure 3). These results may be more attributed to a
genetic pattern than to protein levels, showing the
importance of the B cell mediated immune response in
our model. Indeed, it has been shown that B cells are
required to prime memory T cell responses, placing the
B and T cell relationship in relevant context to vaccine
biology [15].
Taken together, these results demonstrated that dur-
ing the activation of the immune system B cells can
modulate the response, mainly by inducing CD8 T lym-
phocytes. This modulation can be responsible for indu-
cing protection. Additionally, that is the first time that
an in vivo DNA-vaccine model showed the importance
of B cells in CD8 T cell activation.
Conclusion
The immune response against DNA-Hsp65 showed a
complex network of APC types and nuclear cytokine
factors. We are the first to demonstrate the participation
of pcDNA3-Hsp65-electroporated B lymphocytes as
antigen presenting cells able to induce CD8 T cells
Figure 1 Proliferation of CD4 and CD8 T lymphocytes obtained after pcDNA3-HSP65 immunization. (A-B) C57BL/6 wild-type (WT) mice
were immunized three times with 100 μg of naked pcDNA3 encoding M. leprae 65-kDa heat shock protein (pcDNA3-HSP65)/mouse in fifteen
days interval. Fifteen (A) or thirty days (B) after the last immunization, the spleens were cultured in the presence of peritoneal macrophages and
50 μg of recombinant Hsp5 for three days to re-stimulate Hsp65 specific cells. CD8 and CD4 T cells were sorted and incubated for three days
with different antigen presenting cells that had been previously electroporated with pcDNA3, pcDNA3-Hsp65 or a mock control (medium). The
proliferation was measured by CFSE staining dilution by flow cytometry and the mock control values were subtracted from the mock vector and
pcDNA3-Hsp65 ones. Assays were performed in triplicate and the results represent the mean ± SD of at least two independent experiments.
*P < 0,05 versus other stimuli (One-way ANOVA with Tukey’s post-test). (C-D) Gene profile of GATA3, T-bet and Foxp3 from total RNA of both
population were evaluated by real-time PCR 15 (C) and 30 (D) days after the last dose of the vaccine and incubated for three days with B cells
as previously described. The level of expression was calculated using the mock cell as an internal control. The data is representative of 2
independent experiments.
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activation. Overall, these data open perspectives to study
B cells and how they can be harnessed to optimize the
DNA vaccine strategies and consequently the immunity
against M. tuberculosis.
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